INVX Innovex International, Inc

Gabelli Funds LLC reduced its stake in Innovex International, Inc. (NYSE:INVX) by 15.3% in the second quarter, decreasing its holdings to 360,100 shares valued at $5.625 million. Despite this reduction, several other institutional investors increased their positions in INVX during the same period, including US Bancorp DE, First Horizon Advisors Inc., Smartleaf Asset Management LLC, PNC Financial Services Group Inc., and Police & Firemen s Retirement System of New Jersey. Innovex International's stock recently opened at $23.07, and the company has received a consensus "Buy" rating from analysts with an average target price of $16.50.

Gamco Investors INC. ET AL sold 54,334 shares of Innovex International, Inc. (NYSE:INVX) during the second quarter, reducing its stake by 2.5% to 2,107,321 shares valued at approximately $32.92 million. Analyst sentiment for Innovex is improving, with Weiss Ratings upgrading the stock to "buy" and MarketBeat showing a consensus "Buy" rating with an average target price of $16.50. The company's stock opened at $23.38, near its 52-week high, and has a market capitalization of $1.61 billion.

Fisher Asset Management LLC reduced its stake in Innovex International ($INVX) by 55.8% in Q2, selling 171,207 shares and retaining 135,475 shares valued at $2.12 million. Despite this, other institutions like Wellington Management and Investment Management Associates significantly increased their holdings. Analysts maintain a "Buy" consensus rating for Innovex, with an average target price of $16.50, following a recent upgrade by Weiss Ratings.

Innovex International (NYSE:INVX) reached a new 52-week high, trading at $23.38 with a significant intraday gain. Despite a "Moderate Buy" consensus from analysts, the current share price significantly exceeds their $16.50 target. The company demonstrates strong fundamentals, including a $1.62 billion market cap, a P/E of 15.94, and solid liquidity, yet recently reported a quarterly loss per share.

Innovex International Inc.'s stock hit a 52-week high of $23.12, reflecting a 46.78% increase over the past year and underscoring strong investor confidence. The company's financial health is rated "GREAT" by InvestingPro, with significant revenue growth and a healthy return on equity. This milestone follows a strong third-quarter 2025 earnings report where EPS and revenue significantly exceeded analyst expectations.

Brandes Investment Partners LP significantly increased its stake in Innovex International, Inc. (NYSE:INVX) by 7.7% in Q2, now owning 10.26% of the company, valued at $110.19 million. Despite a consensus "Moderate Buy" rating and a price target of $16.50, the stock is currently trading around $22.59, presenting a discrepancy between analyst targets and market price. Several other institutional investors also adjusted their positions, while the company's fundamentals show strong liquidity and low debt, alongside a recent quarterly loss.